Completed PHASE3 INTERVENTIONAL 2-arm NCT04621058

Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.

Efficacy of Treatment With Vitamin D in Patients Diagnosed With COVID-19 Who Presenting Vitamin D Deficiency and Pneumonia.

Sponsor: Bioaraba Health Research Institute

Conditions SAR SARS Pneumonia

Interventions PLACEBO Vitamin D

Updated 5 times since 2020 Last updated: Jul 14, 2022 Started: Nov 9, 2020 Primary completion: Nov 30, 2021 Completion: Nov 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04621058, this PHASE3 trial focuses on SAR and SARS Pneumonia and remains completed. Sponsored by Bioaraba Health Research Institute, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Sep 2022 — Jul 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jan 2021 — Sep 2022 [monthly]

Recruiting PHASE3
Dec 2020 — Jan 2021 [monthly]

Recruiting PHASE3

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bioaraba Health Research Institute
Fundación Eduardo Anitua

Data source: Bioaraba Health Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vitoria-Gasteiz, Spain